Related Tags >> FDA Phase III GlaxoSmithKline FDA approval

FDA approvable letter News

Most Popular FDA approvable letter Story

FDA delays Roche's blockbuster Actemra

September 19, 2008 — 9:20am ET | By John Carroll

The FDA is delaying approval of Roche's new rheumatoid arthritis drug Actemra, saying that it wants to Read more...

FDA approvable letter Press Releases

FDA Issues Approvable Letter for RISPERDALÂ® to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar M

Latest Headlines

FDA delays approval of AMAG anemia drug
October 20, 2008
FDA delays Roche's blockbuster Actemra
September 19, 2008
Cardiome shares plunge on approvable letter
August 11, 2008
FDA goes neutral with new response letters
July 10, 2008
ALSO NOTED: Medicines Company gets not approvable letter; Sun, Taro merger called off; and much more...
May 28, 2008
Discovery secures $60M financing deal
May 27, 2008
Wyeth gets approvable letter for bazedoxifene
May 23, 2008
Merck shelves study of cholesterol drug
May 21, 2008
ALSO NOTED: Salix gets approvable letter; Intermune drug hits the fast track; and much more...
May 19, 2008
FDA delays Entereg decision
May 9, 2008
Battered Discovery Labs tries to reassure investors
May 5, 2008
FDA delays Discovery Labs approval
May 2, 2008
Drug work completed, Theravance cuts 40% of staff
April 23, 2008
Endo pulls Frova app after mulling FDA response
April 8, 2008
Avanir gets $40 to wrap new Phase III for Zenvia
March 27, 2008
Basilea shares plunge on antibiotic delay
March 18, 2008
FDA to review Theravance's telavancin response
March 6, 2008
ALSO NOTED: Amgen analysts bearish; FDA hands Kyowa not-approvable letter; Valeant plans review; and much more...
February 28, 2008
Blogster sees lessons in FDA approvable letters
February 21, 2008
GSK, Adolor face another Entereg delay
February 11, 2008

Paid Research Reports

More Research Reports >>